We are live on ! Find out more
REPL icon

Replimune Group

110 hedge funds and large institutions have $1.34B invested in Replimune Group in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

26% more capital invested

Capital invested by funds: $1.06B → $1.34B (+$276M)

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

2% more funds holding

Funds holding: 108110 (+2)

3% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 38

0.1% less ownership

Funds ownership: 74.91%74.81% (-0.1%)

23% less call options, than puts

Call options by funds: $1.56M | Put options by funds: $2.02M

Holders
110
Holders Change
+2
Holders Change %
+1.85%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
39
Reduced
38
Closed
12
Calls
$1.56M
Puts
$2.02M
Net Calls
-$465K
Net Calls Change
+$2.62M

REPL Hedge Fund Activity: Q2 2021 in Review

110 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2021, worth a combined $1.34B — up 26% from $1.06B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new REPL positions and 12 closed out — a net gain of 3 holders — while 39 added to existing stakes and 38 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $68.1M. The largest seller was Corriente Advisors, cutting an estimated $21.4M.

  • 110 institutional investors held Replimune Group (REPL) as of Q2 2021, up from 108 in Q1 2021.
  • Funds reported $1.34B of Replimune Group stock for Q2 2021, up 26% quarter-over-quarter.
  • 15 funds opened new Replimune Group positions in Q2 2021 and 12 closed out, a net change of +3 holders.
  • The largest Replimune Group buyer in Q2 2021 was T. Rowe Price Associates, an estimated $68.1M added.
  • The largest Replimune Group seller in Q2 2021 was Corriente Advisors, an estimated $21.4M sold.

Based on aggregated 13F filings for Q2 2021.